1010090-SD: Bard Avitene Microfibrillar Collagen Hemostat Sheet (Non-Woven Web) 70mm x 35mm (2.8" x 1.4")

Sign in to add this product to your favorites!
Price: | $74.99 EACH |
---|---|
Quantity: | |
In Stock: | 8 eaches |
Expiration: | 06-2025 |
Related Items
G21049-SD $1,299.99 EACH Cook Hemospray Endoscopic Hemostat with 10F Catheter Exp: 07-2025 Units in stock: 2 | Order Qty |
EPAC-2 $2,400.00 EACH Olympus EndoClot Air Compressor, Reusable Air Source for EndoClot PHS In-Date Units in stock: 1 | Order Qty |
G56572-SD $1,299.99 EACH Cook Hemospray Endoscopic Hemostat with 7F Catheter Exp: 10-2025 Units in stock: 1 | Order Qty |
AM0004-SD $14.99 EACH Bard Arista AH FlexiTip Applicator 14cm (Includes 2 Applicators) Exp: 07-2025 Units in stock: 4 | Order Qty |
1503832-SD $375.69 per box of 12 Baxter Ostene Bone Hemostasis Material 2.5g Exp: 08-2025 Units in stock: 6 box of 12 | Order Qty |
1503832-SD $31.84 EACH Baxter Ostene Bone Hemostasis Material 2.5g Exp: 08-2025 Units in stock: 5 | Order Qty |
Additional Details
BD Bard Avitene Microfibrillar Collagen Hemostat Sheet
Avitene™ Microfibrillar Collagen Hemostat is an active collagen hemostat, proven to help accelerate clot formation. Avitene™ effectively enhances platelet aggregation and the release of proteins to form fibrin, resulting in hemostasis.
Product Code: 1010090
- Non-Woven Web
- 7.0cm x 3.5cm (2.8" x 1.4")
- Cut to any shape or size
- Ideal for flat surfaces or to wrap vessels and anastomosis sites
Key Specifications
- Brand: Becton-Dickinson / C.R. Bard
- Product Type: Biosurgery / Hemostasis
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.